Protein Supply in Elderly

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

16 participants

Study Classification

INTERVENTIONAL

Study Start Date

2010-06-30

Study Completion Date

2011-02-28

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Stimulating overnight muscle protein synthesis, might augment muscle hypertrophy, increase mitochondrial mass, and/or improve muscle tissue repair. The goal of this proposal will be to provide further insight into the responsiveness of the muscle protein synthetic machinery to food intake in relation to age.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Combined Nutrient Intake and Muscle Protein Synthesis

NCT01239277

Aging

COMPLETED NA

Dietary Strategies to Promote Muscle Protein Anabolism in the Elderly

NCT00557388

Sarcopenia

COMPLETED NA

The Anabolic Properties of Fortified Plant-based Protein in Older People

NCT05711095

Muscle Protein Synthesis Sarcopenia

COMPLETED NA

A Protein Supplementation and Exercise Strategy to Promote Muscle Protein Anabolism in Frail Elderly People

NCT01110369

Sarcopenia

COMPLETED NA

Dietary Interventions for Muscle Mass

NCT01145131

Aging

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Muscle Synthesis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

DOUBLE

Participants Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Protein

Protein drink

Group Type EXPERIMENTAL

Protein

Intervention Type DIETARY_SUPPLEMENT

Protein drink

Placebo

water

Group Type PLACEBO_COMPARATOR

Protein

Intervention Type DIETARY_SUPPLEMENT

Protein drink

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Protein

Protein drink

Intervention Type DIETARY_SUPPLEMENT

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

casein vs water

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Males
* Age between 65 and 80 years
* BMI \< 30 kg/m2

Exclusion Criteria

* Type 2 diabetic patients
* Use of medication
* All co morbidities interacting with mobility and muscle metabolism of the lower limbs (e.g. artrosis, arthritis, spasticity/rigidity, all neurological disorders and paralysis).
* Use of anticoagulants, blood diseases, allergy for lidocain.
* Contra indications for the use of a nasogastric tube: high risk of aspiration, gastric stasis, gastro-oesophageal reflux, upper gastrointestinal stricture, nasal injuries and base of skull fractures.
* Patients suffering from PKU (Phenylketonuria).

Minimum Eligible Age

65 Years

Maximum Eligible Age

80 Years

Eligible Sex

MALE

Accepts Healthy Volunteers

Yes